Zentek (CVE:ZEN) Stock Price Up 41.8% - Here's Why

Key Points

• Zentek Ltd. shares surged by 41.8% on Wednesday, reaching a high of C$1.70, with a notable trading volume of 407,343 shares, which is a 752% increase from the average.
• The company has a market capitalization of C$135.08 million, a debt-to-equity ratio of 4.97, and operates with a negative P/E ratio of -16.13.
• Zentek specializes in the research and development of graphene and related nanomaterials, producing products such as antimicrobial coatings, surgical masks, and rapid diagnostics tests.

Shares of Zentek Ltd. (CVE:ZEN - Get Free Report) shot up 41.8% on Wednesday . The stock traded as high as C$1.70 and last traded at C$1.29. 407,343 shares were traded during trading, an increase of 752% from the average session volume of 47,792 shares. The stock had previously closed at C$0.91.

Zentek Price Performance

The company has a market capitalization of C$122.51 million, a P/E ratio of -14.63 and a beta of 0.29. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97. The business has a 50 day simple moving average of C$1.20 and a 200-day simple moving average of C$1.57.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.